|
US2472133A
(en)
|
1947-03-20 |
1949-06-07 |
Du Pont |
Thiophanthraquinone derivatives
|
|
SU1049490A1
(ru)
|
1982-05-18 |
1983-10-23 |
Ордена Трудового Красного Знамени Институт Химии Ан Мсср |
(3 @ ,9 @ ,9 @ )-6,6,9 @ -Триметилтранспергидронафто(2,1- @ )фуран,в качестве душистого компонента парфюмерной композиции
|
|
JPS63196576A
(ja)
|
1987-02-10 |
1988-08-15 |
Tetsuo Ikegawa |
フラルナフトキノン誘導体と制癌剤及びその製造方法
|
|
US5846534A
(en)
|
1988-02-12 |
1998-12-08 |
British Technology Group Limited |
Antibodies to the antigen campath-1
|
|
JPH04139177A
(ja)
|
1989-12-28 |
1992-05-13 |
Dainippon Ink & Chem Inc |
フラルベンゾキノン誘導体及びその製造方法並びに制癌剤
|
|
EP0466094B1
(en)
|
1990-07-10 |
1999-03-24 |
Canon Kabushiki Kaisha |
Electrophotographic photosensitive member
|
|
TW252136B
(https=)
|
1992-10-08 |
1995-07-21 |
Ciba Geigy |
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
MD1367C2
(ro)
|
1992-11-13 |
2000-11-30 |
Idec Pharmaceuticals Corporation |
Metode de tratament al limfomului celulelor B, anticorpi anti-CD20, hibridom.
|
|
US5595721A
(en)
|
1993-09-16 |
1997-01-21 |
Coulter Pharmaceutical, Inc. |
Radioimmunotherapy of lymphoma using anti-CD20
|
|
GB9603507D0
(en)
|
1996-02-20 |
1996-04-17 |
Isis Innovation |
Antibody variants
|
|
JP3598168B2
(ja)
|
1996-03-18 |
2004-12-08 |
独立行政法人 科学技術振興機構 |
抗ウイルス剤
|
|
US20020032315A1
(en)
|
1997-08-06 |
2002-03-14 |
Manuel Baca |
Anti-vegf antibodies
|
|
US20020173629A1
(en)
|
1997-05-05 |
2002-11-21 |
Aya Jakobovits |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
JPH1121284A
(ja)
|
1997-06-30 |
1999-01-26 |
Kotobuki:Kk |
フラノナフトキノン誘導体及びこれを含有する医薬
|
|
JPH1165141A
(ja)
|
1997-08-11 |
1999-03-05 |
Canon Inc |
電子写真感光体、該電子写真感光体を有するプロセスカ−トリッジ及び電子写真装置
|
|
US6174913B1
(en)
|
1998-06-05 |
2001-01-16 |
The University Of North Carolina At Chapel Hill |
Naphtho- and dihydrobenzo-thiophene derivatives as cytotoxic antitumor agents
|
|
US6682736B1
(en)
|
1998-12-23 |
2004-01-27 |
Abgenix, Inc. |
Human monoclonal antibodies to CTLA-4
|
|
US7109003B2
(en)
|
1998-12-23 |
2006-09-19 |
Abgenix, Inc. |
Methods for expressing and recovering human monoclonal antibodies to CTLA-4
|
|
EP1897540A3
(en)
|
1999-01-27 |
2008-07-23 |
University Of South Florida |
Inhibition of STAT3 signal transduction for human cancer therapy
|
|
JP2003525862A
(ja)
|
1999-01-27 |
2003-09-02 |
ザ ユニヴァーシティー オブ サウス フロリダ |
ヒト癌の治療のためのｓｔａｔ３シグナル伝達の阻害
|
|
EP1985285A3
(en)
|
1999-04-01 |
2009-08-12 |
Hana Biosciences, Inc. |
Compositions and methods for treating lymphoma
|
|
US6482943B1
(en)
|
1999-04-30 |
2002-11-19 |
Slil Biomedical Corporation |
Quinones as disease therapies
|
|
KR100466730B1
(ko)
|
1999-08-02 |
2005-01-24 |
에프. 호프만-라 로슈 아게 |
신규한 선택적 레티노이드 작용물질
|
|
US7605238B2
(en)
|
1999-08-24 |
2009-10-20 |
Medarex, Inc. |
Human CTLA-4 antibodies and their uses
|
|
IL148079A0
(en)
|
1999-08-24 |
2002-09-12 |
Medarex Inc |
Human ctla-4 antibodies and compositions containing the same
|
|
JP2001097860A
(ja)
|
1999-09-29 |
2001-04-10 |
Japan Science & Technology Corp |
抗薬剤耐性菌剤と抗クラミジア剤
|
|
UA75055C2
(uk)
|
1999-11-30 |
2006-03-15 |
Пфайзер Продактс Інк. |
Похідні бензоімідазолу, що використовуються як антипроліферативний засіб, фармацевтична композиція на їх основі
|
|
KR20010100194A
(ko)
|
2000-03-13 |
2001-11-14 |
박호군 |
여러 가지 물질의 가용화용 조성물과 제형 및 그들의제조방법
|
|
ATE513563T1
(de)
|
2000-10-09 |
2011-07-15 |
Isis Innovation |
Therapeutische und toleranz-induzierende antikörper
|
|
US7090843B1
(en)
|
2000-11-28 |
2006-08-15 |
Seattle Genetics, Inc. |
Recombinant anti-CD30 antibodies and uses thereof
|
|
WO2002078617A2
(en)
|
2001-03-28 |
2002-10-10 |
University Of South Florida |
Materials and methods for treatment of cancer and identification of anti-cancer compounds
|
|
GB0117696D0
(en)
|
2001-07-20 |
2001-09-12 |
Bradford Particle Design Plc |
Particle information
|
|
US20040092428A1
(en)
|
2001-11-27 |
2004-05-13 |
Hongming Chen |
Oral pharmaceuticals formulation comprising paclitaxel, derivatives and methods of administration thereof
|
|
AU2002351177A1
(en)
|
2001-11-29 |
2003-06-10 |
Therakos, Inc. |
Methods for pretreating a subject with extracorporeal photopheresis and/or apoptotic cells
|
|
JP2005526084A
(ja)
|
2002-03-15 |
2005-09-02 |
ナットイムネ・アクティーゼルスカブ |
マンノース結合レクチンを含む医薬組成物
|
|
US7435797B2
(en)
|
2002-04-10 |
2008-10-14 |
Genentech, Inc. |
Anti-HER2 antibody variants
|
|
ES2350687T3
(es)
|
2002-07-03 |
2011-01-26 |
Ono Pharmaceutical Co., Ltd. |
Composiciones de inmunopotenciación.
|
|
EP2357009A1
(en)
|
2002-07-15 |
2011-08-17 |
Board of Regents, The University of Texas System |
Duramycin peptide binding to anionic phospholipids and aminophospholipids conjugates and their use in treating viral infections
|
|
EP1551392A4
(en)
|
2002-09-17 |
2006-09-20 |
Arqule Inc |
NEW LAPACHO COMPOUNDS AND APPLICATION METHOD THEREFOR
|
|
CN101928344B
(zh)
|
2002-10-17 |
2014-08-13 |
根马布股份公司 |
抗cd20的人单克隆抗体
|
|
TWI323662B
(en)
|
2002-11-15 |
2010-04-21 |
Telik Inc |
Combination cancer therapy with a gst-activated anticancer compound and another anticancer therapy
|
|
CL2003002353A1
(es)
|
2002-11-15 |
2005-02-04 |
Vertex Pharma |
Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
|
|
IS6633A
(is)
|
2002-11-22 |
2004-05-23 |
Omega Farma Ehf. |
Samsetningar af fínasteríð töflum
|
|
EP1639090A4
(en)
|
2003-06-09 |
2008-04-16 |
Univ Michigan |
COMPOSITIONS AND METHODS OF TREATMENT AND DIAGNOSIS OF CANCER
|
|
CN102558352A
(zh)
|
2003-06-27 |
2012-07-11 |
艾默根佛蒙特有限公司 |
针对表皮生长因子受体的缺失突变体的抗体及其使用
|
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
US7758859B2
(en)
|
2003-08-01 |
2010-07-20 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
US20050049207A1
(en)
|
2003-09-03 |
2005-03-03 |
Kaufmann Doug A. |
Method of treating and preventing cancer
|
|
WO2005033048A2
(en)
|
2003-09-29 |
2005-04-14 |
The Johns Hopkins University |
Wnt pathway antagonists
|
|
US7288638B2
(en)
|
2003-10-10 |
2007-10-30 |
Bristol-Myers Squibb Company |
Fully human antibodies against human 4-1BB
|
|
WO2005042581A2
(en)
|
2003-11-01 |
2005-05-12 |
Biovation Ltd. |
Modified anti-cd52 antibody
|
|
AU2004296828B2
(en)
|
2003-12-02 |
2011-07-07 |
Cleveland Clinic Foundation |
Methods of protecting against radiation using flagellin
|
|
PT1701941E
(pt)
|
2003-12-11 |
2012-08-03 |
Univ Texas |
Compostos para o tratamento de doenças proliferativas celulares
|
|
DE10359828A1
(de)
|
2003-12-12 |
2005-07-28 |
Zoser B. Dr.Rer.Nat. Salama |
CHP-Gemcitabin- Kombinationsmittel und ihre Verwendung als Antitumorwirkstoffe, insbesondere Antimetastasierungswirkstoffe
|
|
CA2563305A1
(en)
|
2004-04-09 |
2005-11-24 |
University Of South Florida |
Combination therapies for cancer and proliferative angiopathies
|
|
JP2004224802A
(ja)
|
2004-04-21 |
2004-08-12 |
Japan Science & Technology Agency |
抗菌剤
|
|
EP2287195B1
(en)
|
2004-07-01 |
2019-05-15 |
Novo Nordisk A/S |
Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy
|
|
JP2008505112A
(ja)
|
2004-07-02 |
2008-02-21 |
イコス・コーポレイション |
Ｃｈｋ１の阻害に有用な化合物
|
|
KR20140032004A
(ko)
|
2004-07-22 |
2014-03-13 |
제넨테크, 인크. |
Ｈｅｒ２ 항체 조성물
|
|
DE602005017283D1
(de)
|
2004-08-18 |
2009-12-03 |
Astrazeneca Ab |
Ausgewählte kondensierte heterocyclen und deren anwendung
|
|
AU2005304952B2
(en)
|
2004-11-08 |
2013-04-04 |
Baxter Healthcare S.A. |
Nanoparticulate compositions of tubulin inhibitors
|
|
RU2007123675A
(ru)
|
2004-11-24 |
2008-12-27 |
Новартис АГ (CH) |
Комбинации ингибиторов jak
|
|
US7951374B2
(en)
|
2004-12-14 |
2011-05-31 |
University Of South Florida |
Methods for inhibiting STAT3 signaling in immune cells
|
|
WO2006071812A2
(en)
|
2004-12-23 |
2006-07-06 |
H. Lee Moffitt Cancer Center And Research Institute |
Platinum iv complex inhibitor
|
|
CA2599393A1
(en)
|
2005-02-25 |
2006-08-31 |
The Regents Of The University Of Michigan |
Small molecule inhibitors of stat3 and the uses thereof
|
|
JP2006248978A
(ja)
|
2005-03-10 |
2006-09-21 |
Mebiopharm Co Ltd |
新規なリポソーム製剤
|
|
JP2006290871A
(ja)
|
2005-03-16 |
2006-10-26 |
Taheebo Japan Kk |
抗癌性を示す化合物およびその中間体ならびにそれらの製造方法
|
|
US20060252073A1
(en)
|
2005-04-18 |
2006-11-09 |
Regents Of The University Of Michigan |
Compositions and methods for the treatment of cancer
|
|
RU2494107C2
(ru)
|
2005-05-09 |
2013-09-27 |
Оно Фармасьютикал Ко., Лтд. |
Моноклональные антитела человека к белку программируемой смерти 1 (pd-1) и способы лечения рака с использованием анти-pd-1-антител самостоятельно или в комбинации с другими иммунотерапевтическими средствами
|
|
CN104356236B
(zh)
|
2005-07-01 |
2020-07-03 |
E.R.施贵宝&圣斯有限责任公司 |
抗程序性死亡配体1(pd-l1)的人单克隆抗体
|
|
US20070009532A1
(en)
|
2005-07-06 |
2007-01-11 |
Branimir Sikic |
Treatment of patients with cancer using a calicheamicin-antibody conjugate in combination with zosuquidar
|
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
|
AR057579A1
(es)
|
2005-11-23 |
2007-12-05 |
Merck & Co Inc |
Compuestos espirociclicos como inhibidores de histona de acetilasa (hdac)
|
|
JP2007145680A
(ja)
|
2005-11-30 |
2007-06-14 |
Idemitsu Kosan Co Ltd |
水素発生材料および水素発生方法
|
|
BRPI0620624A2
(pt)
|
2005-12-24 |
2011-11-16 |
Biotica Tech Ltd |
análogo de 21-deóximacbecina ou um sal farmaceuticamente aceitável do mesmo, método para a produção do mesmo, composição farmacêutica, cepas hospedeira e engenheirada, e, uso das mesmas
|
|
CA2635209A1
(en)
|
2006-01-12 |
2007-08-02 |
Merck & Co., Inc. |
Fluorinated arylamide derivatives
|
|
WO2007092620A2
(en)
|
2006-02-09 |
2007-08-16 |
Macusight, Inc. |
Stable formulations, and methods of their preparation and use
|
|
WO2007100640A2
(en)
|
2006-02-21 |
2007-09-07 |
The Regents Of The University Of Michigan |
Growth hormone receptor antagonist cancer treatment
|
|
AU2007218966A1
(en)
|
2006-02-24 |
2007-08-30 |
Merck Frosst Canada Ltd. |
2-(phenyl or heterocyclic) - 1h-phenanthro [9,10-d] imidazoles
|
|
BRPI0709916B8
(pt)
|
2006-03-31 |
2021-05-25 |
Univ Texas |
drogas anticâncer associadas ao ácido caféico biodisponível por via oral e uso das referidas drogas
|
|
US20070238770A1
(en)
|
2006-04-05 |
2007-10-11 |
Bristol-Myers Squibb Company |
Process for preparing novel crystalline forms of peliglitazar, novel stable forms produced therein and formulations
|
|
WO2008094321A2
(en)
|
2006-10-04 |
2008-08-07 |
Universtiy Of South Florida |
Akt sensitization of cancer cells
|
|
WO2008077062A2
(en)
|
2006-12-19 |
2008-06-26 |
Board Of Regents, The University Of Texas System |
Suppression of stat3 reactivation after src kinase inhibition to treat cancer
|
|
JP4077863B1
(ja)
|
2007-05-31 |
2008-04-23 |
タヒボジャパン株式会社 |
抗癌活性を有する光学活性２−（１−ヒドロキシエチル）−５−ヒドロキシナフト［２，３−ｂ］フラン−４，９−ジオンの製法
|
|
HRP20131167T1
(hr)
|
2007-06-18 |
2014-01-03 |
Merck Sharp & Dohme B.V. |
Antitijela za humani receptor programirane smrti pd-1
|
|
JP2010537640A
(ja)
|
2007-08-27 |
2010-12-09 |
ボストン バイオメディカル， インコーポレイテッド |
マイクロｒｎａ模倣剤または阻害剤としての非対称性ｒｎａ二重鎖の組成物
|
|
EP3050566B1
(en)
|
2007-09-10 |
2018-11-28 |
Boston Biomedical, Inc. |
A novel group of stat3 pathway inhibitors and cancer stem cell pathway inhibitors
|
|
EP2044949A1
(en)
|
2007-10-05 |
2009-04-08 |
Immutep |
Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
|
|
WO2009060282A2
(en)
|
2007-11-06 |
2009-05-14 |
Orchid Research Laboratories Limited |
Stilbene derivatives as pstat3/il-6 inhibitors
|
|
US20100297118A1
(en)
|
2007-12-27 |
2010-11-25 |
Macdougall John |
Therapeutic Cancer Treatments
|
|
WO2010014784A2
(en)
|
2008-08-01 |
2010-02-04 |
Bristol-Myers Squibb Company |
Combination of anti-ctla4 antibody with diverse therapeutic regimens for the synergistic treatment of proliferative diseases
|
|
WO2010098788A2
(en)
|
2008-08-25 |
2010-09-02 |
Amplimmune, Inc. |
Pd-i antagonists and methods for treating infectious disease
|
|
AU2009333580B2
(en)
|
2008-12-09 |
2016-07-07 |
Genentech, Inc. |
Anti-PD-L1 antibodies and their use to enhance T-cell function
|
|
EP2998405B1
(en)
|
2009-05-13 |
2019-12-11 |
Genzyme Corporation |
Anti-human cd52 immunoglobulins
|
|
US8267122B2
(en)
|
2009-06-30 |
2012-09-18 |
Ge Aviation Systems Llc |
Method and systems for bleed air supply
|
|
NZ628923A
(en)
|
2009-11-24 |
2016-02-26 |
Medimmune Ltd |
Targeted binding agents against b7-h1
|
|
WO2011066342A2
(en)
|
2009-11-24 |
2011-06-03 |
Amplimmune, Inc. |
Simultaneous inhibition of pd-l1/pd-l2
|
|
WO2011084694A1
(en)
|
2009-12-17 |
2011-07-14 |
University Of Pittsburgh-Of The Commonwealth System Of Higher Education |
Stabilized stat3 decoy oligonucleotides and uses therefor
|
|
JP5998060B2
(ja)
|
2010-03-04 |
2016-09-28 |
マクロジェニクス，インコーポレーテッド |
Ｂ７−ｈ３と反応性のある抗体、その免疫学的に活性なフラグメントおよびその使用
|
|
PH12012501751A1
(en)
|
2010-03-04 |
2012-11-12 |
Macrogenics Inc |
Antibodies reactive with b7-h3, immunologically active fragments thereof and uses thereof
|
|
EP2547205B1
(en)
|
2010-03-19 |
2024-03-20 |
1Globe Biomedical Co., Ltd. |
Novel methods for targeting cancer stem cells
|
|
PT2547205T
(pt)
|
2010-03-19 |
2024-05-27 |
1Globe Biomedical Co Ltd |
Novos métodos para atingir células estaminais cancerígenas
|
|
RU2571661C2
(ru)
|
2010-03-19 |
2015-12-20 |
Бостон Байомедикал, Инк. |
Новые соединения и композиции для нацеливания на злокачественные стволовые клетки
|
|
AU2015218436B9
(en)
|
2010-03-19 |
2017-03-09 |
Boston Biomedical, Inc. |
Novel Methods For Targeting Cancer Stem Cells
|
|
JP5208239B2
(ja)
|
2010-09-29 |
2013-06-12 |
タヒボジャパン株式会社 |
アルキンカップリングによる抗がん活性三環式化合物の新規製法
|
|
US9150530B2
(en)
|
2011-03-04 |
2015-10-06 |
Zhoushan Haizhongzhou Xinsheng Pharmaceuticals Co., Ltd. |
Esters of 4, 9-dihydroxy-naphtho [2, 3-b] furans for disease therapies
|
|
ES2676205T3
(es)
|
2011-03-31 |
2018-07-17 |
Merck Sharp & Dohme Corp. |
Formulaciones estables de anticuerpos para el receptor PD-1 humano de muerte programada y tratamientos relacionados
|
|
US8977803B2
(en)
|
2011-11-21 |
2015-03-10 |
Western Digital Technologies, Inc. |
Disk drive data caching using a multi-tiered memory
|
|
WO2013166618A1
(en)
|
2012-05-08 |
2013-11-14 |
Zhoushan Haizhongzhou Xinsheng Pharmaceuticals Co., Ltd. |
PRODRUGS OF 4,9-DIHYDROXY-NAPHTHO[2,3-b]FURANS FOR CIRCUMVENTING CANCER MULTIDRUG RESISTANCE
|
|
CN113967253A
(zh)
|
2012-05-15 |
2022-01-25 |
百时美施贵宝公司 |
通过破坏pd-1/pd-l1信号传输的免疫治疗
|
|
WO2013172918A1
(en)
|
2012-05-15 |
2013-11-21 |
University Of Southern California |
Ksr1 gene polymorphism for use in predicting outcome and therapy selection
|
|
AR091649A1
(es)
|
2012-07-02 |
2015-02-18 |
Bristol Myers Squibb Co |
Optimizacion de anticuerpos que se fijan al gen de activacion de linfocitos 3 (lag-3) y sus usos
|
|
EP2983790A2
(en)
|
2013-04-09 |
2016-02-17 |
Boston Biomedical, Inc. |
Methods for treating cancer
|
|
JP6199787B2
(ja)
|
2014-03-28 |
2017-09-20 |
京セラドキュメントソリューションズ株式会社 |
画像形成装置
|
|
JP2016531151A
(ja)
|
2013-09-13 |
2016-10-06 |
バイエル ファーマ アクチエンゲゼルシャフト |
レファメチニブを含有する医薬組成物
|
|
CA2942877A1
(en)
|
2014-04-08 |
2015-10-15 |
Nitzan SHAHAR |
Unit dosage form comprising emtricitabine, tenofovir, darunavir and ritonavir
|
|
US10005752B2
(en)
|
2014-06-09 |
2018-06-26 |
Kyoto Pharmaceutical Industries, Ltd. |
Anticancer agent
|
|
JP2016016973A
(ja)
|
2014-07-10 |
2016-02-01 |
株式会社リコー |
シート処理装置
|
|
WO2016030455A1
(en)
|
2014-08-28 |
2016-03-03 |
Medimmune Limited |
Anti-b7-h1 and anti-ctla-4 antibodies for treating non-small lung cancer
|
|
CN106470697B
(zh)
|
2014-09-16 |
2019-10-25 |
兴盟生物医药(苏州)有限公司 |
抗egfr抗体以及其用途
|
|
US10183925B2
(en)
|
2015-03-27 |
2019-01-22 |
Boston Biomedical, Inc. |
Substituted naphtho[2,3-b]furans as water-soluble prodrugs for preventing and/or treating cancer
|
|
TW201709905A
(zh)
|
2015-04-17 |
2017-03-16 |
波士頓生醫公司 |
治療癌症之方法
|
|
US20180085341A1
(en)
|
2015-04-17 |
2018-03-29 |
Boston Biomedical, Inc. |
Methods for treating cancer
|
|
BR112017022269A2
(pt)
|
2015-04-17 |
2018-07-10 |
Boston Biomedical Inc |
métodos para tratar câncer
|
|
CN107683137A
(zh)
|
2015-04-27 |
2018-02-09 |
波士顿生物医药有限公司 |
用于使用stat3途径抑制剂和激酶抑制剂治疗癌症的方法
|
|
MX2017015618A
(es)
|
2015-06-03 |
2018-08-15 |
Boston Biomedical Inc |
Composiciones que comprenden un inhibidor de la autorrenovación y diferenciación de células madre cancerosas y un agente inmunoterapéutico para su uso en el tratamiento del cáncer.
|
|
WO2017013865A1
(ja)
|
2015-07-17 |
2017-01-26 |
大日本住友製薬株式会社 |
２－アセチル－４Ｈ，９Ｈ－ナフト［２，３－ｂ］フラン－４，９－ジオンの製造方法
|
|
WO2017132049A1
(en)
|
2016-01-20 |
2017-08-03 |
Boston Biomedical, Inc. |
Methods for treating cancer
|
|
WO2017164379A1
(ja)
|
2016-03-25 |
2017-09-28 |
大日本住友製薬株式会社 |
２－アルキルカルボニルナフト［２，３－ｂ］フラン－４，９－ジオンの関連物質の製造方法、及びその関連物質
|
|
US20190375723A1
(en)
|
2016-11-22 |
2019-12-12 |
Boston Biomedical, Inc. |
New Naphtho[2,3-B]Furan Derivatives
|
|
CA3058162A1
(en)
|
2017-03-30 |
2018-10-04 |
Boston Biomedical, Inc. |
Compositions for treating and/or preventing cancer
|
|
CA3062656A1
(en)
|
2017-05-17 |
2018-11-22 |
Boston Biomedical, Inc. |
Methods for treating cancer
|
|
JP2019110987A
(ja)
|
2017-12-21 |
2019-07-11 |
オムロンヘルスケア株式会社 |
測定装置およびプログラム
|